Evidence map›Paper›PMID 22540535›Full record

ReviewFEMS immunology and medical microbiology2012

The role of Borrelia burgdorferi outer surface proteins.

Melisha R Kenedy, Tiffany R Lenhart, Darrin R Akins

Abstract readReview
In one paragraph

Review in FEMS immunology and medical microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 158 citations in OpenAlex.

  1. Review
  2. Review
  3. The Lyme Disease Vaccine Paradox.Journal of clinical medicine · 2026
    Article
  4. Article
  5. Article
  6. Frontiers in immunology · 2026
    Article
  7. Article
  8. Article
  9. A Lyme disease mRNA vaccine targetingMolecular therapy. Nucleic acids · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Tick-to-host transmission differs betweenMicrobiology spectrum · 2023
    Article
  19. Review
  20. Development of an mRNA-lipid nanoparticle vaccine against Lyme disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Melisha R KenedyDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Tiffany R Lenhart
Darrin R Akins
University of Oklahoma Health Sciences Center · US

Funding

Outer Membrane Proteins of Borrelia burgdorferiR01AI059373 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI AKINS, DARRIN R. · 2005 to 2022
$4.7M
Surface Lipoproteins and Serum Resistance in Borrelia burgdorferiR21AI085310 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI AKINS, DARRIN R. · 2010 to 2011
$402k
Outer membrane proteins of Borrelia burgdorferiR56AI059373 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI AKINS, DARRIN R. · 2011 to 2011
$329k
NIAID NIH HHS AI059373NIAID NIH HHS AI085310NIAID NIH HHS R01 AI059373NIAID NIH HHS R21 AI085310NIAID NIH HHS R56 AI059373
6 · The paper itself

Abstract

Human pathogenic spirochetes causing Lyme disease belong to the Borrelia burgdorferi sensu lato complex. Borrelia burgdorferi organisms are extracellular pathogens transmitted to humans through the bite of Ixodes spp. ticks. These spirochetes are unique in that they can cause chronic infection and persist in the infected human, even though a robust humoral and cellular immune response is produced by the infected host. How this extracellular pathogen is able to evade the host immune response for such long periods of time is currently unclear. To gain a better understanding of how this organism persists in the infected human, many laboratories have focused on identifying and characterizing outer surface proteins of B. burgdorferi. As the interface between B. burgdorferi and its human host is its outer surface, proteins localized to the outer membrane must play an important role in dissemination, virulence, tissue tropism, and immune evasion. Over the last two decades, numerous outer surface proteins from B. burgdorferi have been identified, and more recent studies have begun to elucidate the functional role(s) of many borrelial outer surface proteins. This review summarizes the outer surface proteins identified in B. burgdorferi to date and provides detailed insight into the functions of many of these proteins as they relate to the unique parasitic strategy of this spirochetal pathogen.

Indexed as

Immune EvasionAnimalsBacterial Outer Membrane ProteinsBorrelia burgdorferi GroupHumansIxodesMembrane ProteinsVirulence FactorsBacterial Outer Membrane ProteinsMembrane ProteinsVirulence Factors

Identifiers

PMID22540535
PMCPMC3424381
OpenAlexW2016555093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.